Secondary Myelofibrosis
Also known as: SMF / Myelofibrosis / Myelofibrosis due to another disorder (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB12500 | Fedratinib | Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.[L8090,L47016] |